EricJEichhornMD
Cardiology • Dallas, TXAdult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology
Cardiologist, Dallas Cardiovascular Specialists
Dr. Eichhorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7777 Forest Ln
Ste C339
Dallas, TX 75230Phone+1 972-566-8855Fax+1 972-566-7509
Education & Training
Tufts Medical CenterFellowship, Cardiovascular Disease, 1985 - 1986
Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1983 - 1985
Baylor College of MedicineResidency, Internal Medicine, 1981 - 1982- Baylor College of MedicineInternship, Internal Medicine, 1979 - 1980
- Baylor College of MedicineClass of 1979
Certifications & Licensure
TX State Medical License 1980 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure Start of enrollment: 2007 Mar 01
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Start of enrollment: 2010 Sep 01
- INcrease Of VAgal TonE in CHF Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- 683 citationsA trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.Eric J. Eichhorn, Michael J. Domanski, Heidi Krause-Steinrauf, Michael R. Bristow, Philip W. Lavori
The New England Journal of Medicine. 2001-05-31 - 128 citationsA comparative analysis of the results from 4 trials of β-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUSMichael J. Domanski, Heidi Krause-Steinrauf, Barry M. Massie, Prakash Deedwania, Dean Follmann
Journal of Cardiac Failure. 2003-10-01 - 70 citationsEffects of bucindolol on neurohormonal activation in congestive heart failureEric J. Eichhorn, A. Iain McGhie, John B. Bedotto, James Corbett, Craig R. Malloy
The American Journal of Cardiology. 1991-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
